Kangmei Pharmaceutical Co., Ltd. (600572.SH) controlling shareholder intends to increase its stake in the company by 1.999%.

Zhijing Finance APP News, Kangmei (600572.SH) announced that, based on the firm confidence in the company's development prospects, recognition of the long-term investment value of the company, and the need to further enhance control, the controlling shareholder of the company, Zhejiang Medicine Group, plans to increase its holdings of the company's shares through block trading on the Shanghai Stock Exchange within 3 months after the disclosure of this announcement, with a planned increase of 50,659,000 shares, accounting for 1.999% of the company's current total share capital.